Literature DB >> 24281367

Microcephaly with or without chorioretinopathy, lymphoedema, or mental retardation (MCLMR): review of phenotype associated with KIF11 mutations.

Gabriela E Jones1, Pia Ostergaard2, Anthony T Moore3, Fiona C Connell4, Denise Williams5, Oliver Quarrell6, Angela F Brady7, Isabel Spier8, Filiz Hazan9, Oana Moldovan10, Dagmar Wieczorek11, Barbara Mikat11, Florence Petit12, Christine Coubes13, Robert A Saul14, Glen Brice15, Kristiana Gordon16, Steve Jeffery2, Peter S Mortimer16, Pradeep C Vasudevan1, Sahar Mansour15.   

Abstract

Microcephaly with or without chorioretinopathy, lymphoedema, or mental retardation (MCLMR) (MIM No.152950) is a rare autosomal dominant condition for which a causative gene has recently been identified. Mutations in the kinesin family member 11 (KIF11) gene have now been described in 16 families worldwide. This is a review of the condition based on the clinical features of 37 individuals from 22 families. This report includes nine previously unreported families and additional information for some of those reported previously. The condition arose de novo in 8/20 families (40%). The parental results were not available for two probands. The mutations were varied and include missense, nonsense, frameshift, and splice site and are distributed evenly throughout the KIF11 gene. In our cohort, 86% had microcephaly, 78% had an ocular abnormality consistent with the diagnosis, 46% had lymphoedema, 73% had mild-moderate learning difficulties, 8% had epilepsy, and 8% had a cardiac anomaly. We identified three individuals with KIF11 mutations but no clinical features of MCLMR demonstrating reduced penetrance. The variable expression of the phenotype and the presence of mildly affected individuals indicates that the prevalence may be higher than expected, and we would therefore recommend a low threshold for genetic testing.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24281367      PMCID: PMC3938398          DOI: 10.1038/ejhg.2013.263

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  23 in total

1.  Lissencephaly and mild cerebellar vermis hypoplasia in a case of microcephaly and chorioretinal dysplasia.

Authors:  Byung Joo Lee; Jeong Hun Kim; Young Suk Yu
Journal:  Ophthalmic Genet       Date:  2010-06       Impact factor: 1.803

2.  Mutations in KIF11 cause autosomal-dominant microcephaly variably associated with congenital lymphedema and chorioretinopathy.

Authors:  Pia Ostergaard; Michael A Simpson; Antonella Mendola; Pradeep Vasudevan; Fiona C Connell; Andreas van Impel; Anthony T Moore; Bart L Loeys; Arash Ghalamkarpour; Alexandros Onoufriadis; Ines Martinez-Corral; Sophie Devery; Jules G Leroy; Lut van Laer; Amihood Singer; Martin G Bialer; Meriel McEntagart; Oliver Quarrell; Glen Brice; Richard C Trembath; Stefan Schulte-Merker; Taija Makinen; Miikka Vikkula; Peter S Mortimer; Sahar Mansour; Steve Jeffery
Journal:  Am J Hum Genet       Date:  2012-01-26       Impact factor: 11.025

Review 3.  Microcephaly-lymphoedema-chorioretinal dysplasia: three cases to delineate the facial phenotype and review of the literature.

Authors:  Pradeep C Vasudevan; Sixto Garcia-Minaur; Maria Pilar Botella; Antonio Perez-Aytes; Nora L Shannon; Oliver W J Quarrell
Journal:  Clin Dysmorphol       Date:  2005-07       Impact factor: 0.816

4.  Microcephaly with chorioretinal degeneration.

Authors:  L O Atchaneeyasakul; L Linck; R G Weleber
Journal:  Ophthalmic Genet       Date:  1998-03       Impact factor: 1.803

Review 5.  The classification and diagnostic algorithm for primary lymphatic dysplasia: an update from 2010 to include molecular findings.

Authors:  F C Connell; K Gordon; G Brice; V Keeley; S Jeffery; P S Mortimer; S Mansour; P Ostergaard
Journal:  Clin Genet       Date:  2013-06-27       Impact factor: 4.438

Review 6.  Microcephaly syndromes.

Authors:  Dianne Abuelo
Journal:  Semin Pediatr Neurol       Date:  2007-09       Impact factor: 1.636

7.  Microcephaly-lymphedema syndrome: report of a family with short stature as additional manifestation.

Authors:  S Strenge; U G Froster
Journal:  Am J Med Genet       Date:  1998-12-28

8.  Mutational spectrum of the oral-facial-digital type I syndrome: a study on a large collection of patients.

Authors:  Clelia Prattichizzo; Marina Macca; Valeria Novelli; Giovanna Giorgio; Adriano Barra; Brunella Franco
Journal:  Hum Mutat       Date:  2008-10       Impact factor: 4.878

9.  The predictive value of microcephaly during the first year of life for mental retardation at seven years.

Authors:  H Dolk
Journal:  Dev Med Child Neurol       Date:  1991-11       Impact factor: 5.449

10.  A novel KIF11 mutation in a Turkish patient with microcephaly, lymphedema, and chorioretinal dysplasia from a consanguineous family.

Authors:  Filiz Hazan; Pia Ostergaard; Taylan Ozturk; Esin Kantekin; Fusun Atlihan; Steve Jeffery; Ferda Ozkinay
Journal:  Am J Med Genet A       Date:  2012-05-31       Impact factor: 2.802

View more
  31 in total

Review 1.  Congenital focal abnormalities of the retina and retinal pigment epithelium.

Authors:  Yingna Liu; Anthony T Moore
Journal:  Eye (Lond)       Date:  2020-05-04       Impact factor: 3.775

2.  A Novel Mutation of KIF11 in a Child with 22q11.2 Deletion Syndrome Associated with MCLMR.

Authors:  Nilay Güneş; Emre Taşdemir; Heather Jeffery; Hüseyin Yetik; Pia Ostergaard; Beyhan Tüysüz
Journal:  Mol Syndromol       Date:  2018-07-20

Review 3.  An approach to familial lymphoedema.

Authors:  Gabriela E Jones; Sahar Mansour
Journal:  Clin Med (Lond)       Date:  2017-12       Impact factor: 2.659

Review 4.  A New Way to Treat Brain Tumors: Targeting Proteins Coded by Microcephaly Genes?: Brain tumors and microcephaly arise from opposing derangements regulating progenitor growth. Drivers of microcephaly could be attractive brain tumor targets.

Authors:  Patrick Y Lang; Timothy R Gershon
Journal:  Bioessays       Date:  2018-03-26       Impact factor: 4.345

Review 5.  Congenital microcephaly and chorioretinopathy due to de novo heterozygous KIF11 mutations: five novel mutations and review of the literature.

Authors:  Ghayda M Mirzaa; Laura Enyedi; Gretchen Parsons; Sarah Collins; Livija Medne; Carissa Adams; Thomas Ward; Bradley Davitt; Alma Bicknese; Elaine Zackai; Helga Toriello; William B Dobyns; Susan Christian
Journal:  Am J Med Genet A       Date:  2014-08-12       Impact factor: 2.802

6.  Novel compound heterozygous variants in PLK4 identified in a patient with autosomal recessive microcephaly and chorioretinopathy.

Authors:  Makiko Tsutsumi; Setsuri Yokoi; Fuyuki Miya; Masafumi Miyata; Mitsuhiro Kato; Nobuhiko Okamoto; Tatsuhiko Tsunoda; Mami Yamasaki; Yonehiro Kanemura; Kenjiro Kosaki; Shinji Saitoh; Hiroki Kurahashi
Journal:  Eur J Hum Genet       Date:  2016-09-21       Impact factor: 4.246

7.  Clinical Interpretation of Sequence Variants.

Authors:  Junyu Zhang; Yanyi Yao; Haixian He; Jun Shen
Journal:  Curr Protoc Hum Genet       Date:  2020-06

8.  Mutations in TUBGCP4 alter microtubule organization via the γ-tubulin ring complex in autosomal-recessive microcephaly with chorioretinopathy.

Authors:  Sophie Scheidecker; Christelle Etard; Laurence Haren; Corinne Stoetzel; Sarah Hull; Gavin Arno; Vincent Plagnol; Séverine Drunat; Sandrine Passemard; Annick Toutain; Cathy Obringer; Mériam Koob; Véronique Geoffroy; Vincent Marion; Uwe Strähle; Pia Ostergaard; Alain Verloes; Andreas Merdes; Anthony T Moore; Hélène Dollfus
Journal:  Am J Hum Genet       Date:  2015-03-26       Impact factor: 11.025

9.  Inter-organelle interactions between the ER and mitotic spindle facilitates Zika protease cleavage of human Kinesin-5 and results in mitotic defects.

Authors:  Liqiong Liu; Micquel Downs; Jesse Guidry; Edward J Wojcik
Journal:  iScience       Date:  2021-03-31

10.  Retinal Features of Family Members With Familial Exudative Vitreoretinopathy Caused By Mutations in KIF11 Gene.

Authors:  Hiroyuki Kondo; Itsuka Matsushita; Tatsuo Nagata; Etsuko Fujihara; Katsuhiro Hosono; Eiichi Uchio; Yoshihiro Hotta; Shunji Kusaka
Journal:  Transl Vis Sci Technol       Date:  2021-06-01       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.